13 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/14/25 15:35
10/13/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticRocklin Amy MMIOGC3M.d1065.410206550D
10/14/25 15:24
10/13/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticJones Douglas EdwardMIOFormer C3M.d1555.540284689D
10/14/25 14:59
10/13/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticAdent John EdwardMIOFormer C3M.d3985.5507227333D
10/9/25 17:03
10/7/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticWoteki Catherine EMID1M.d125.63021615D
10/9/25 17:00
10/7/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticTobin James PMID1M.d125.6302640D
10/9/25 16:58
10/7/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticRodriguez Rafael AMID1M.d125.63021417D
10/9/25 16:54
10/7/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticGupta AashimaMID1M.d125.6302924D
10/9/25 16:51
10/7/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticGreen Ronald DMID1M.d125.63021615D
10/9/25 16:48
10/7/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticCapello Jeffrey DMID1M.d125.6302829D
10/9/25 16:44
10/7/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticBorel James CMID1M.d125.6302293D
10/9/25 16:36
10/7/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticBoehm William TMID1M.d125.6302638D
8/20/25 11:57
8/18/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticNaemura David H.MIOCFO1M.d785.430142670D
8/20/25 10:23
8/18/25
NEOGHealthDiagnIn Vitro & In Vivo DiagnosticMoylan John PatrickMIOChief Ac1M.d115.43021614D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact